Shanghai Sanyou Medical (688085) 证券之星·2025-03-26 13:25Core Viewpoint - The report provides a verification of Shanghai Sanyou Medical Instrument Co., Ltd.'s pre-investment of self-raised funds into fundraising projects and payment of issuance expenses, confirming compliance with regulatory requirements [1][3]. Group 1: Verification Report - The verification report is intended solely for the purpose of replacing self-raised funds with raised funds for investment projects and issuance expenses [2]. - The management of Sanyou Medical is responsible for providing accurate and complete information in accordance with regulatory guidelines [2]. - The registered accountants conducted the verification in accordance with Chinese CPA standards, ensuring that the information is free from material misstatement [2]. Group 2: Fundraising Overview - The total amount raised from the issuance is RMB 213,999,988.12, with net proceeds after fees amounting to RMB 203,920,127.60 [4][5]. - The company incurred a financial advisory and underwriting fee of RMB 8,702,599.81, which includes VAT [5]. - The net amount raised was verified by an external accounting firm, providing a verification report [4]. Group 3: Investment Project Details - The company plans to use the raised funds primarily for cash consideration in transactions, with 93.85% allocated for this purpose [5]. - As of February 28, 2025, the actual investment amount from self-raised funds into the projects was RMB 57,217,758.05, representing 26.74% of the total planned usage [5][6]. - Specific allocations include RMB 20,084.88 million for cash consideration and RMB 1,315.12 million for intermediary fees and taxes [5]. Group 4: Issuance Expense Payments - The total amount paid from self-raised funds for issuance expenses was RMB 975,324.54 [6]. - Breakdown of issuance expenses includes RMB 821.00 million for financial advisory and underwriting fees, and RMB 101.89 million for audit and verification fees [8].